ChestLink is the first fully autonomous AI medical imaging product with a CE mark. ChestLink identifies CXRs with no abnormality and produces finalized patient reports without any intervention from the radiologist, reducing radiologist workload and enabling them to focus on cases with pathologies.
Product specifications Information source: Vendor
Last updated: April 8, 2022
General
Product name ChestLink
Company Oxipit
Subspeciality Chest
Modality X-ray
Disease targeted Algorithms support 75 different pathologies
Key-features Autonomous healthy patients report generation
Suggested use Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population Older than 18 years old
Input PA or PA + LAT Digital Chest X Ray
Input format DICOM
Output Report for healthy patients
Output format DICOM SR or HL7 message
Technology
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition
Processing time 10 - 60 seconds
Certification
CE
Certified, Class IIb , MDR
FDA
No or not yet
Market presence
On market since 03-2022
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance

  • USING ARTIFICIAL INTELLIGENCE TO DETECT CHEST X-RAYS WITH NO SIGNIFICANT FINDINGS IN A PRIMARY HEALTH CARE SETTING IN OULU, FINLAND (read)

Other relevant papers